Latest Tech Advancements Revitalize Tomorrow’s Engineering Technology Career Opportunities
DeVry University’s engineering technology degree programs keep pace to provide students with the advanced IT skills needed for careers in...
News
Breakthrough in Device Therapy for Patients with Late-Stage Heart Disease
SWANSEA, Wales and TEL AVIV, Israel, Jan. 10, 2022 /PRNewswire/ -- Severe heart failure is the most life-threatening medical condition in...
Fortified Health Security CEO Dan L. Dodson Elected to the Association for Executives in Healthcare Information Security (AEHIS) Board of Trustees
Joins group of prominent healthcare cybersecurity visionaries in advancing organization's mission of serving senior IT executives while advocating for the...
Mercator MedSystems Announces Receipt of NIH Grant for Research and Development of Local Anti-inflammatory Deep Vein Thrombosis Therapy
EMERYVILLE, CA / ACCESSWIRE / January 10, 2022 / Mercator MedSystems, Inc. ("Mercator" or the "company"), announced today that research...
Eyam Vaccines and Immunotherapeutics Welcomes New Board Members and Scientific Advisors
VANCOUVER, BC / ACCESSWIRE / January 10, 2022 / Eyam Vaccines and Immunotherapeutics is pleased to publicly announce the appointment...
Nutriband Inc. And Kindeva Drug Delivery Sign Feasibility Agreement to Develop AVERSA(TM) Fentanyl, an Abuse Deterrent Fentanyl Patch
ORLANDO, FL / ACCESSWIRE / January 10, 2022 / Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW) today announced the signing of a feasibility agreement...
Moderna Announces Advances Across Its Industry-Leading mRNA Pipeline and Provides Business Update
807 million doses of Moderna's COVID-19 vaccine shipped globally in 2021; approximately 25% of those doses shipped to low- and...
Zomedica CEO Provides Update to Shareholders
ANN ARBOR, MI / ACCESSWIRE / January 10, 2022 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary...
Moderna and Carisma Establish Collaboration to Develop in vivo Engineered Chimeric Antigen Receptor Monocytes (CAR-M) for Oncology
Collaboration will combine Carisma's engineered macrophage technology with Moderna's mRNA and LNP technologies to generate and develop in vivo CAR-M...
NeuroMetrix Names Strategic Growth Executive, Brandi Damkier, as Vice President, Clinical Partnerships
WOBURN, Mass., Jan. 10, 2022 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today announced that it has appointed Brandi Damkier...
NGM Bio Outlines 2022 Strategic Priorities Across Its Portfolio of Clinical-Stage Oncology, Retinal and Liver and Metabolic Programs
After a transformative year in 2021, NGM Bio enters 2022 with a diverse pipeline of seven disclosed programs, including four...
Assertio Holdings, Inc. to Participate in the H.C. Wainwright BioConnect Virtual Conference
LAKE FOREST, Ill., Jan. 10, 2022 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or “the Company”) (NASDAQ: ASRT) today announced...
Artelo Biosciences Leadership to Participate on Endocannabinoid Panel at the H.C. Wainwright BioConnect 2022 Virtual Conference
Artelo CEO also providing corporate outlook for 2022 at the H.C. Wainwright ConferenceSOLANA BEACH, Calif., Jan. 10, 2022 (GLOBE NEWSWIRE)...
Seer, Discovery Life Sciences and SCIEX Announce First-Of-Its-Kind Proteogenomics Consortium for Large-Scale Studies
Delivery of 100,000 samples of capacity annually to the market, empowering genomics researchers to add deep, unbiased proteomics analysis to...
HealthEquity Announces Record HSA Sales Outlook, Presentation at J.P. Morgan Healthcare Conference
DRAPER, Utah., Jan. 10, 2022 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ: HQY) (“HealthEquity” or the “Company”), the nation’s largest independent...
Castellum, Inc. Announces Promotion of Glen Ives to President of Government Sales and Operations; Additional Executive Moves Noted
Castellum, Inc. Announces Promotion of Glen Ives to President of Government Sales and Operations; Additional Executive Moves Noted Castellum, Inc....
CareCentrix Named a 2022 “Fierce 15” Company by Fierce Healthcare
Fierce Recognizes CareCentrix’s HomeFirstSM Analytics and Hyper-Personalized Care Model as Innovations in Health at Home HARTFORD, Conn., Jan. 10, 2022...
Junshi Biosciences and Coherus Expand Immuno-Oncology Collaboration to Include TIGIT-Targeted Antibody
Junshi Biosciences and Coherus plan to evaluate the toripalimab + JS006 combination in clinical trials in multiple tumor typesCombinations of...
Biofrontera Inc. Announces Participation in Two Dermatology Conferences in January
WOBURN, Mass., Jan. 10, 2022 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI) (the “Company”), a biopharmaceutical company specializing in the...
Clover Health Beats Expectations with Medicare Advantage Membership Growing by Over 25% at the Start of 2022
Fueled by strong performance in New Jersey and GeorgiaNASHVILLE, Tenn., Jan. 10, 2022 (GLOBE NEWSWIRE) -- Today, Clover Health (Nasdaq:...